• Explore /
  • Poster
  • / A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC).

A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC).

Abstract Video & Slides Poster

Authors

Oliver Zivanovic

Oliver Zivanovic

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

Oliver Zivanovic , Dennis Chi , Qin Zhou , Alexia Iasonos , Vicky Makker , Rachel N. Grisham , Jason A. Konner , John Paul Diaz , Amy K. Brown , Carrie L Langstraat , Viktoriya Paroder , Krysten Soldan , Katy Su , Ginger J. Gardner , Elizabeth Lin Jewell , Kara Long , William P. Tew , Stuart M. Lichtman , Yukio Sonoda , Roisin Eilish O'Cearbhaill

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01767675

Citation

J Clin Oncol 38: 2020 (suppl; abstr 6016)

DOI

10.1200/JCO.2020.38.15_suppl.6016

Abstract #

6016

Poster Bd #

187

Abstract Disclosures

Similar Posters

First Author: Radoslav Chekerov

First Author: Erika Joelle Lampert

First Author: Jacek P. Grabowski

First Author: Gwenael Ferron